Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 14 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

21%

3 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

6(54.5%)

Phase 4

3(27.3%)

Phase 2

2(18.2%)

11Total

N/A(6)

Phase 4(3)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials

NCT05005117Not ApplicableActive Not Recruiting

Laparoscopic Approach for Emergency Colon Resection

Role: collaborator

NCT05766202Not ApplicableCompleted

The MOTIVE (Multiparas Overcoming Childbirth Fear Through Intervention and Empowerement) Feasibility Trial

Role: collaborator

NCT04385745Not ApplicableCompleted

Treatment of Children's Forearm Shaft Fractures With Biodegradable Intramedullary Nailing, Compared With Elastic Stable Intramedullary Nailing

Role: collaborator

NCT04978259Phase 4Unknown

SOLIDARITY Finland Long-COVID (Remdesivir Long-term Follow-up Study of COVID Patients)

Role: collaborator

NCT05220280Phase 4Unknown

SOLIDARITY Finland Plus Long-COVID

Role: collaborator

NCT01080404Not ApplicableUnknown

A Study of Surgical Weight Loss to Treat Obstructive Sleep Apnea

Role: collaborator

NCT03732131Recruiting

The Finnish Faecal Microbiota Transplantation Study (FINFMT)

Role: collaborator

NCT01790737Phase 2Completed

First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02

Role: collaborator

NCT00861250Phase 2Completed

Assessment of Molecular Remission by ASO-qPCR After Bortezomib-dexamethasone (Vel/Dex) Followed by ASCT

Role: collaborator

NCT00908089Phase 4Unknown

TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis

Role: collaborator

NCT01119404Unknown

Hämeenlinna Metabolic Syndrome Research Program: Surrogate Indicators for Atherosclerosis

Role: lead

NCT01119690Not ApplicableCompleted

Hämeenlinna Metabolic Syndrome Research Program: Effects of Rapeseed Oil on Serum Lipids and Platelet Function

Role: lead

NCT01114763Completed

Hämeenlinna Metabolic Syndrome Research Program: Oxidized LDL and Arterial Elasticity in Metabolic Syndrome and Controls (HMS-01)

Role: lead

NCT00349648Not ApplicableUnknown

Conservative or Operative Treatment for the Shoulder Impingement Syndrome?

Role: lead

All 14 trials loaded